{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:36:45Z","timestamp":1756384605228,"version":"3.32.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1136\/ard.59.10.753","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:45:32Z","timestamp":1027766732000},"page":"753-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs"],"prefix":"10.1016","volume":"59","author":[{"given":"Hiske E M","family":"van Dieten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg B C Korthals-de","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurits W","family":"van Tulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem F","family":"Lems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben A C","family":"Dijkmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Boers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1995","series-title":"Arthritis and allied conditions.","author":"McCarthy","key":"10.1136\/ard.59.10.753_bib1"},{"key":"10.1136\/ard.59.10.753_bib2","first-page":"98","article-title":"Nonsteroidal antiinflammatory drugs; benefit\/risk evaluation in rheumatic diseases.","volume":"19(suppl 32)","author":"Fenner","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.10.753_bib3","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1001\/archinte.1992.00400220033006","article-title":"Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis.","volume":"152","author":"Greene","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.59.10.753_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9343(98)00072-2","article-title":"Recent considerations in nonsteroidal anti-inflammatory drug gastropathy.","volume":"105","author":"Singh","year":"1998","journal-title":"Am J Med"},{"key":"10.1136\/ard.59.10.753_bib5","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.59.10.753_bib6","first-page":"2","article-title":"Epidemiology of NSAID induced gastropathy.","volume":"18 (suppl 28)","author":"Zeidler","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.10.753_bib7","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1001\/archinte.1994.00420180022003","article-title":"Is misoprostol cost-effective in the prevention of nonsteroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis?","volume":"154","author":"Stucki","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.59.10.753_bib8","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/art.1780400907","article-title":"A summary of economic evaluations published in the field of rheumatology and related disciplines.","volume":"40","author":"Ferraz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.10.753_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/00019053-199508060-00004","article-title":"Economic and quality-of-life impact of NSAIDs in rheumatoid arthritis: a conceptual framework and selected literature review.","volume":"8","author":"Gabriel","year":"1995","journal-title":"Pharmacoeconomics"},{"key":"10.1136\/ard.59.10.753_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00019053-199507020-00002","article-title":"Preventing NSAID-induced gastrointestinal toxicity; economic considerations, methodological problems and results.","volume":"7","author":"de Pouvourville","year":"1995","journal-title":"Pharmacoeconomics"},{"year":"1997","series-title":"Methods for the economic evaluation of health care programmes.","author":"Drummond","key":"10.1136\/ard.59.10.753_bib11"},{"year":"1999","series-title":"Back schools for nonspecific back pain (Cochrane Review). The Cochrane Library, Issue 3.","author":"Van Tulder","key":"10.1136\/ard.59.10.753_bib12"},{"key":"10.1136\/ard.59.10.753_bib13","first-page":"187","article-title":"Economic evaluation of prophylactic treatment with misoprostol in osteoarthritic patients treated with NSAIDs. The case of Belgium.","volume":"38","author":"Carrin","year":"1990","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1136\/ard.59.10.753_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.1990.03450010045028","article-title":"Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding.","volume":"264","author":"Edelson","year":"1990","journal-title":"JAMA"},{"key":"10.1136\/ard.59.10.753_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/art.1780370306","article-title":"A costs-utility analysis of misoprostol prophylaxis for rheumatoid arthritis patients receiving nonsteroidal antiinflammatory drugs.","volume":"37","author":"Gabriel","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.10.753_bib16","first-page":"1412","article-title":"Economic evaluation using mathematical models: the case of misoprostol prophylaxis.","volume":"22","author":"Gabriel","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.10.753_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.1780360404","article-title":"The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events.","volume":"36","author":"Gabriel","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.10.753_bib18","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0149-2918(97)80021-5","article-title":"Management of NSAID-induced gastropathy: an economic decision analysis.","volume":"196","author":"Goldstein","year":"1997","journal-title":"Clin Ther"},{"key":"10.1136\/ard.59.10.753_bib19","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/archinte.1989.00390090105021","article-title":"Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs.","volume":"149","author":"Hillman","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.59.10.753_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1017\/S0266462300013465","article-title":"Cost-effectiveness of misoprostol in Sweden.","volume":"8","author":"J\u00c3\u00b6nsson","year":"1992","journal-title":"Intl J Technol Assess Health Care"},{"key":"10.1136\/ard.59.10.753_bib21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/pgmj.66.778.639","article-title":"Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non steroidal anti-inflammatory drugs.","volume":"66","author":"Knill-Jones","year":"1990","journal-title":"Postgrad Med J"},{"key":"10.1136\/ard.59.10.753_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/1529-0131(199801)41:1<16::AID-ART3>3.0.CO;2-4","article-title":"The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs.","volume":"41","author":"Maetzel","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.10.753_bib23","first-page":"366","article-title":"Die kosten-effectivit\u00c3\u00a4t der Misoprostoltherapie in der pr\u00c3\u00a4vention NSAR-induzierter magenulzera.","volume":"107","author":"Schwarz","year":"1995","journal-title":"Wien Klin Wochenschr"},{"key":"10.1136\/ard.59.10.753_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-115-3-195","article-title":"Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer.","volume":"115","author":"Agrawal","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.59.10.753_bib25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(88)92892-9","article-title":"Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.","volume":"ii","author":"Graham","year":"1988","journal-title":"Lancet"},{"key":"10.1136\/ard.59.10.753_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs.","volume":"123","author":"Silverstein","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.59.10.753_bib27","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk of serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis.","volume":"115","author":"Gabriel","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.59.10.753_bib28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archinte.1989.00390050025005","article-title":"Risk and cost of gastrointestinal adverse events associated with nonsteroidal anti-inflammatory drugs.","volume":"149","author":"Bloom","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.59.10.753_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00019053-199916010-00008","article-title":"Diclofenac\/misoprostol; pharmacoeconomics implications of therapy.","volume":"16","author":"Plosker","year":"1999","journal-title":"Pharmacoeconomics"},{"year":"1997","series-title":"Cochrane collaboration handbook. The Cochrane Collaboration. The Cochrane Library [database on disk and CDROM].","author":"Mulrow","key":"10.1136\/ard.59.10.753_bib30"},{"key":"10.1136\/ard.59.10.753_bib31","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1097\/00007632-199710150-00001","article-title":"Method guidelines for systematic reviews in the Cochrane collaboration Back Review Group for spinal disorders.","volume":"22","author":"Van Tulder","year":"1997","journal-title":"Spine"},{"key":"10.1136\/ard.59.10.753_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.313.7052.275","article-title":"Guidelines for authors and peer reviewers of economic submissions to the BMJ.","volume":"313","author":"Drummond","year":"1996","journal-title":"BMJ"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724425041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724425041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.59.10.753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T05:06:28Z","timestamp":1736139988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724425041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["S0003496724425041"],"URL":"https:\/\/doi.org\/10.1136\/ard.59.10.753","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2000,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.59.10.753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Copyright 2000 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}